BH

Bingsong Han

FT Forma Therapeutics: 35 patents #5 of 86Top 6%
VH Valo Health: 13 patents #4 of 53Top 8%
FT Forma Tm: 7 patents #5 of 24Top 25%
NE Neurogen: 7 patents #39 of 120Top 35%
Genentech: 7 patents #424 of 2,392Top 20%
VD Valo Early Discovery: 6 patents #7 of 30Top 25%
NA Novo Nordisk Health Care Ag: 3 patents #20 of 131Top 20%
NP Novartis International Pharmaceutical: 1 patents #29 of 55Top 55%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
📍 Westwood, MA: #1 of 265 inventorsTop 1%
🗺 Massachusetts: #490 of 88,656 inventorsTop 1%
Overall (All Time): #26,124 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 1–25 of 74 patents

Patent #TitleCo-InventorsDate
12336981 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +8 more 2025-06-24
12264137 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2025-04-01
12071440 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell +5 more 2024-08-27
12053458 Treating sickle cell disease with a pyruvate kinase R activating compound Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell +5 more 2024-08-06
11980611 Treating sickle cell disease with a pyruvate kinase R activating compound Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell +5 more 2024-05-14
11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, David R. Lancia, Jr., Cuixian Liu, Matthew W. Martin +5 more 2024-03-05
11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2024-02-06
11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell +5 more 2023-05-16
11547701 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +8 more 2023-01-10
11535607 Isoindolines as HDAC inhibitors Xiaozhang Zheng, Matthew W. Martin, Pui Yee Ng, Jennifer R. Thomason, Aleksandra Rudnitskaya +1 more 2022-12-27
11479564 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Judith D. Kuntz +5 more 2022-10-25
11414392 [6,6] fused bicyclic HDAC8 inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Nicholas Barczak +4 more 2022-08-16
11345672 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, David R. Lancia, Jr. +6 more 2022-05-31
11279687 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Jian Lin +5 more 2022-03-22
11279681 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2022-03-22
11274085 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2022-03-15
11274084 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2022-03-15
11247987 Inhibiting ubiquitin specific peptidase 30 Justin Andrew Caravella, Cuixian Liu, Stephanos Ioannidis, Alexandre Joseph Buckmelter, David Richard +3 more 2022-02-15
11014927 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Anna Ericsson, Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell +5 more 2021-05-25
10988450 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2021-04-27
10988441 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, David R. Lancia, Jr., Cuixian Liu, Matthew W. Martin +5 more 2021-04-27
10829462 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2020-11-10
10829460 [6,6] fused bicyclic HDAC8 inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Nicholas Barczak +4 more 2020-11-10
10829461 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2020-11-10
10822316 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2020-11-03